The present invention relates to bispecific constructs that specifically bind to immune effector cells and simultaneously to IL23R carrying target cells as well as nucleic acids vectors host cells pharmaceutical compositions and methods of production and use thereof including such bispecific constructs for use in treating inflammatory and/or autoimmune diseases and/or cancer.